Home Options EEMReports

EEM

iShares MSCI Emerging Markets ETFClose $68.60EOD only

Max Pain

$66.00

Next expiry Jun 5, 2026

Expected Move

±$2.21

3.2% from close

Price Gap

-2.60

Distance to max pain

IV Rank

High premium

P/C OI

1.83

Slightly put-heavy

Consensus

5.0/10

Range bias

Published snapshot: May 29, 2026 close

End-of-day snapshot

This page reflects EEM options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot

May 29, 2026 close

EEM Theta Report

Analysis based on market close April 17, 2026

Directional Theta Gang Flow Earnings Consensus

Historical consensus-supported lens with full content, report chain context, and metric rail.

You are viewing an older report from April 17, 2026. A newer theta report is available for May 26, 2026.

View latest report

Theta Verdict

Confidence:

8 / 10

base 5; +2 GEX/flow strongly aligned; +1 GEX positive (pinning); -1 spot 8.8% from MP; +1 VIX 17

IV Environment

IV Regime

Normal

IV vs VIX

EEM IVs elevated vs VIX; 0d ATM 14.65, 7d ATM ~18, 30d ATM ~22, 60d ATM ~25; VIX ~17

Favorable?

Yes

Term structure: Steep front-week put skew and higher mid-dated IVs; weekly expiries in 2 and 9 trading days increasing roll risk

📌Pinning regime with max-pain clustered at $58-$60

⚠️Short-dated put IV concentrated; 0–7d skew heavy — watch for >+8 vol-point jumps

📅Event slate: weekly expiries + macro prints (CPI/Fed speakers) this week — increases tail risk

Pin Risk Assessment

Spot vs MP: Above

GEX regime: Pinning ($+1.1B)

Gamma flip: ~$55.00 — Approx — based on put OI concentration of 218,270 (13.6% below spot)

OI concentrations: Put OI concentrated ~13.6% below spot; max-pain at $58/$60; ~12% of open premium rolls across next weekly expiry

Verdict: Elevated pin risk near $58-$60; downside flow could push spot toward $55 gamma-flip and spike IVs/GEX impact

Premium Opportunities

Put credit spread

Sell 2026-05-08 $61.50/$61.00 put spread

Sell 2026-05-08 61.50/61.00 put spread to capture elevated short-dated put IV with a tight 1¢ wing.

Credit: $0.12-$0.15

Max loss: $0.35

BE: $61.35

Mgmt: Close or roll if spot nears 61.50, IV spikes >+8 pts, or spot drops toward $55 gamma-flip. Liquidity warning: Liquidity constraints: short_put: Open interest below 25.; long_put: Open interest below 25.

Cash-secured put

Sell 2026-05-15 $61.00 cash-secured put

Sell 2026-05-15 $61 cash‑secured put to collect elevated premium and set an entry into stock.

Credit: $0.62-$0.75

Max loss: $60.25

BE: $60.25

Mgmt: Manage by buying back if IV explodes or spot breaches invalidation 61.46; monitor margin and roll to further expiries.

Covered call

Buy shares + sell 2026-05-15 $66.00 call

Buy shares and sell 2026-05-15 $66 call to monetize outsized call skew and OI while retaining upside to ~+7% before assignment.

Credit: $0.68-$0.83

Max loss: Stock downside to $0 less call premium

BE: $62.81

Mgmt: Enter when premium ≥$1.10; buy back call if spot >$68 (lock profit >30% on option), or if IV rises >+6 pts or spot drops below $55; roll out one month if assignment risk outweighs tax/transaction costs.

Risk Alerts

!Rapid spot move to ~$55 gamma-flip invalidates premium-selling edge

!Short-dated put IV/skew can spike >+8 vol pts on downside flow

!Dealer GEX currently net-positive (~+$120M) but can flip with large directional selling

!Near-term roll/margin exposure ~12% of premium across weekly expiry — increases forced adjustments

How to Use These Reports

This theta reflects the market close on April 17, 2026.

What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.